CME GROUP INC. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2010 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Cme Group Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q1 2024.
- Cme Group Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$7.4M, a 14.9% increase year-over-year.
- Cme Group Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$75M, a 223% decline from 2022.
- Cme Group Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$23.2M, a 167% decline from 2021.
- Cme Group Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $34.8M.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)